Results 1 to 10 of about 14,672 (166)
Case report and literature review: the effect of surgical management in intrathoracic pseudomyxoma peritonei [PDF]
BackgroundIntrathoracic metastasis in patients with pseudomyxoma peritonei is extremely rare and carries a poor prognosis. No standard treatment recommendations have been established, and it remains unclear whether surgical treatment can improve the long-
De-Wang Ren +5 more
doaj +2 more sources
Classic multivisceral transplant for advanced nonresectable pseudomyxoma peritonei: a case report [PDF]
Background Pseudomyxoma peritonei is uncommon with a poorly understood pathogenesis. The standard treatment is cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. However, radical surgical resection is not feasible for patients
Hamed Nikoupour +7 more
doaj +2 more sources
Beyond the Expected: A Case-Based Exploration and Literature Review on the Rare Evolution of Pseudomyxoma Peritonei From a Side-Branch Intraductal Papillary Mucinous Neoplasm. [PDF]
Objectives We present a case of a ruptured side‐branch intraductal papillary mucinous neoplasm (IPMN) who was found to have pseudomyxoma peritonei (PMP) with a deposit of acellular mucin in the pelvis. Case Presentation The patient is a 65‐year‐old female who initially presented to care with intermittent right upper quadrant pain and fullness ...
Brown NS +3 more
europepmc +2 more sources
An Ayurvedic intervention for pseudomyxoma peritonei - A case report [PDF]
Cancer is the deadliest disease in the world and cancer treatment remains as a challenge among all systems of medicine. Pseudomyxoma peritonei is one of the rarest malignancies, devoid of any promising management strategies.
Divya Sukumar +4 more
doaj +2 more sources
Pseudomyxoma peritonei (PMP) is an uncommon "borderline malignancy" generally arising from a perforated appendiceal epithelial tumour. Optimal treatment involves a combination of cytoreductive surgery (CRS) with heated intraperitoneal chemotherapy (HIPEC). Controversy persists regarding the pathological classification and its prognostic value. Computed
Ming-Jong, Bair +3 more
+8 more sources
High prevalence of KRAS and GNAS mutations in pseudomyxoma peritonei underscores opportunities for targeted therapeutic strategies [PDF]
Pseudomyxoma peritonei (PMP) is a rare, slow-growing cancer with few efficacious treatment options in unresectable cases. Mutations in the KRAS and GNAS oncogenes are common, but the reported frequencies vary greatly, most likely because of low tumor ...
Torgunrud Annette +6 more
doaj +2 more sources
Pseudomyxoma pleurii: unusual location of a rare disease
Pseudomyxoma peritonei with pleural extension is very rare. Dissemination in the pleural cavity can be trans diaphragmatic or hematogenous. Appendicular and ovarian mucinous tumors are the most often involved.
Kaoutar Imrani +4 more
doaj +1 more source
Abstract Pseudomyxoma peritonei is a relatively rare and poorly understood condition in which mucus accumulates within the peritoneal cavity. The presence of cells in the mucin, either inflammatory or neoplastic, distinguishes it from simple acellular mucus ascites caused by mucinous spillage.
Hani, Baradi, Jeffrey, Ponsky
openaire +4 more sources
Inguinal Hernia as an Initial Presentation of Pseudomyxoma Peritonei [PDF]
Pseudomyxoma Peritonei (PMP) is characterized by presence of abundant extracellular mucin in the peritoneum. Preoperative diagnosis of pseudomyxoma peritonei is difficult due to its varied presentation.
Biswajit Dey +4 more
doaj +1 more source
Background Pseudomyxoma peritonei is a rare disease condition mainly caused by primary mucinous tumors from the appendix and rarely from the ovary, such as when mucinous ovarian tumors arise from within a teratoma. Molecular analyses of pseudomyxoma from
Ayumi Taguchi +15 more
doaj +1 more source

